Search research articles
Contact Us
Filters
Showing results (1-10 of 61) with videos related to
Page
of 7
Sort By:
Gastroenterology
|
October 3, 2002
"High-grade MALT" vs. diffuse large B cell lymphoma
Axel Greiner, Stephan Timm
European Journal of Dermatology : EJD
|
June 9, 2009
Cost-effectiveness of biologics for moderate-to-severe psoriasis from the perspective of the Swiss healthcare system
Roger-Axel GREINER, Lasse R Braathen
Nucleic Acids Research
|
March 9, 2004
Myosin light chain 1 atrial isoform (MLC1A) is expressed in pre-B cells under control of the BOB.1/OBF.1 coactivator
Helmut Laumen, Cornelia Brunner, Axel Greiner, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
May 24, 2008
Herpes simplex vegetans: atypical genital herpes infection with prominent plasma cell infiltration in B-cell chronic lymphocytic leukemia
Annette Römer, Axel Greiner, Alexander Enk, et al.
Gastrointestinal Endoscopy
|
October 25, 2002
Diagnostic accuracy of EUS in the local staging of primary gastric lymphoma: results of a prospective, multicenter study comparing EUS with histopathologic stage
Wolfgang Fischbach, Maria-Elisabeth Goebeler-Kolve, Axel Greiner
Swiss Medical Weekly
|
October 4, 2013
Cost-effectiveness of ticagrelor and generic clopidogrel in patients with acute coronary syndrome in Switzerland
David Gasche, Tanja Ulle, Bernhard Meier, et al.
Journal of Cardiovascular Pharmacology
|
October 16, 2021
Prevalence of and Factors Associated With the Prescription of Fibrates Among Patients Receiving Lipid-Lowering Drugs in Germany
Louis Jacob, Roger-Axel Greiner, Mark Luedde, et al.
Leukemia & Lymphoma
|
January 31, 2008
Analysis of CARMA1/BCL10/MALT1 expression in Reed-Sternberg cells of classical Hodgkin lymphoma
Daniel Re, Ingo Hartlapp, Axel Greiner, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
April 15, 2014
Cost-effectiveness of modern mTOR inhibitor based immunosuppression compared to the standard of care after renal transplantation in Germany
Jan Steffen Jürgensen, Robert Ikenberg, Roger-Axel Greiner, et al.
Cancer Letters
|
September 18, 2004
Tumor induction by activated JNK occurs through deregulation of cellular growth
Ulrike Rennefahrt, Bertram Illert, Axel Greiner, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 61) with videos related to
Sort By:
Page
of 7
Gastroenterology
|
October 3, 2002
"High-grade MALT" vs. diffuse large B cell lymphoma
Axel Greiner, Stephan Timm
European Journal of Dermatology : EJD
|
June 9, 2009
Cost-effectiveness of biologics for moderate-to-severe psoriasis from the perspective of the Swiss healthcare system
Roger-Axel GREINER, Lasse R Braathen
Nucleic Acids Research
|
March 9, 2004
Myosin light chain 1 atrial isoform (MLC1A) is expressed in pre-B cells under control of the BOB.1/OBF.1 coactivator
Helmut Laumen, Cornelia Brunner, Axel Greiner, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
May 24, 2008
Herpes simplex vegetans: atypical genital herpes infection with prominent plasma cell infiltration in B-cell chronic lymphocytic leukemia
Annette Römer, Axel Greiner, Alexander Enk, et al.
Gastrointestinal Endoscopy
|
October 25, 2002
Diagnostic accuracy of EUS in the local staging of primary gastric lymphoma: results of a prospective, multicenter study comparing EUS with histopathologic stage
Wolfgang Fischbach, Maria-Elisabeth Goebeler-Kolve, Axel Greiner
Swiss Medical Weekly
|
October 4, 2013
Cost-effectiveness of ticagrelor and generic clopidogrel in patients with acute coronary syndrome in Switzerland
David Gasche, Tanja Ulle, Bernhard Meier, et al.
Journal of Cardiovascular Pharmacology
|
October 16, 2021
Prevalence of and Factors Associated With the Prescription of Fibrates Among Patients Receiving Lipid-Lowering Drugs in Germany
Louis Jacob, Roger-Axel Greiner, Mark Luedde, et al.
Leukemia & Lymphoma
|
January 31, 2008
Analysis of CARMA1/BCL10/MALT1 expression in Reed-Sternberg cells of classical Hodgkin lymphoma
Daniel Re, Ingo Hartlapp, Axel Greiner, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
April 15, 2014
Cost-effectiveness of modern mTOR inhibitor based immunosuppression compared to the standard of care after renal transplantation in Germany
Jan Steffen Jürgensen, Robert Ikenberg, Roger-Axel Greiner, et al.
Cancer Letters
|
September 18, 2004
Tumor induction by activated JNK occurs through deregulation of cellular growth
Ulrike Rennefahrt, Bertram Illert, Axel Greiner, et al.
Page
of 7